Expert Review Committee

Prior to joining the WHO in 2003 as a Medical Officer, Richard spent 13 years at Boston University where he obtained post-graduate degrees in public health and health policy prior to becoming Professor of Public Health at Boston University. He has served on a number of WHO Expert Committees. He has an extensive list of academic publications and is one of the editors and authors of the standard text ‘Managing Drug Supply’. Richard was one of the authors of the ‘Priority Medicines for Europe and the World’ report and has been engaged in working on measurement of medicines pricing and availability as part of the joint WHO/Health Action Iinternational (HAI) project. Currently he edits the Essential Medicines Monitor. Richard Laing is a physician who worked for 18 years in the Ministry of Health in Zimbabwe before joining the WHO.

Eduardo came to the IFPMA from Bristol-Myers Squibb (BMS), a company he joined in 2001, and in which he had risen to the position of Vice-President, International Policy and Government Affairs. Prior to that, Eduardo held positions as legal counsel at Immuno AG in Belgium and Austria, at Baxter Healthcare in Belgium and Italy, and in European Policy and Government Affairs at Adamson Associates and SmithKline Beecham in Belgium. Eduardo started his career in 1989 following his graduation in Law from the University of Catania, Italy. 

Dennis holds a Doctorate in health policy and management from the Harvard School of Public Health. His career has focused on improving health systems in the US and developing countries, including research on the effects of pharmaceutical policies, factors underlying appropriate use of medicines, interventions to improve quality of care, and applied research methodology in low resource settings. He has consulted extensively with the World Health Organization on issues related to access to and appropriate use of medicines, and he co-directs the WHO Collaborating Center on Pharmaceutical Policy.

Dilip also serves as Co-chair of the Federation of Indian Chambers of Commerce and Industry (FICCI) Committee on Pharmaceuticals. Dilip also holds advisory positions as Member of Medicines Transparency Alliance (MeTA) International Advisory Group, UK Department for International Development (DFID). He also is a Member of the Board of Governors of the Institute of Health Management Research, Jaipur, a WHO Collaborative Centre for District Health System based on Primary Healthcare. He is the author of the first book on ‘Drug Pricing in India’ and Editor Asia & India of the Journal of Generic Medicines, UK.

Elias holds numerous positions including fellow of the Faculty of Public Health and of the Royal College of Physicians and Honorary Consultant in Public Health with the South East London NHS Strategic Health Authority.

In 1998, he co-founded the European Observatory on Health Systems and Policies.  In 2002 and 2007, he was recipient of the Baxter Award from the European Health Management Association for the best publication in health policy and management in Europe.

He also served as a president of the Merck Company Foundation. Since 2000, he served as a member of the board of the African Comprehensive HIV/AIDS Partnerships in Botswana (2005-2009) and a member of the private sector delegation to the Board of the Global Fund to Fight AIDS, TB and Malaria (2002-2008). Dr. Sturchio is also a Visiting Scholar at the Institute for Applied Economics and the Study of Business Enterprise at The Johns Hopkins University and a member of the World Economic Forum’s Global Agenda Council on the Healthy Next Generation.